Todd Furness, DO
General Practice · Draper, UTNPI 1285941310
Payments from drug & device makers
Across 493 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$820
- Astellas Pharma US Inc$659
- Lilly USA, LLC$479
- Boston Scientific$401
- Boehringer Ingelheim$399
- plus $4K from 47 others
What the payments were for
- Food & beverage$7,75799%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,857 in reported general payments places this provider in the 95th percentile of 1,070 general practice providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 126 | $157,338 |
| FarxigaDapagliflozin Propanediol | 85 | $90,076 |
| JardianceEmpagliflozin | 41 | $58,920 |
| EliquisApixaban | 54 | $54,927 |
| Tresiba Flextouch U-200Insulin Degludec | 31 | $49,925 |
| TrulicityDulaglutide | 32 | $43,516 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 27 | $42,420 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $37,536 |
| RybelsusSemaglutide | 24 | $34,624 |
| MounjaroTirzepatide | 25 | $31,608 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 12 | $30,389 |
| GemtesaVibegron | 27 | $21,402 |
| XareltoRivaroxaban | 21 | $21,292 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $20,621 |
| VraylarCariprazine Hcl | 11 | $16,576 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Xultophy 100-3.6 | $379 | $222,350162 claims |
| AstraZenecaFarxiga, Symbicort | $344 | $94,27497 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $479 | $75,12457 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $399 | $73,36759 claims |
| PfizerEliquis | $301 | $54,92754 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $251 | $42,42027 claims |
| GSKTrelegy Ellipta | $395 | $37,53636 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $40 | $21,40227 claims |
| Johnson & JohnsonXarelto | $173 | $21,29221 claims |
| AbbVieVraylar | $1,022 | $16,57611 claims |
| BayerKerendia | $119 | $16,11511 claims |
| MerckBelsomra | $139 | $6,05112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,070 general practice providers in Utah.
Other general practice in Draper
- James AndersonRoy$44.1M
- Dan FischerSandy$8.1M
- Jaleena JessopSandy$6.7M
- Melanie HoppersMurray$1.2M
- Ryan LewisSouth Jordan$735K
- Mark LudlowWest Jordan$592K
- Eric SwensenWest Jordan$109K
- Brigham StokerSalt Lake City$82K
- Kelly OlsenSt George$65K
- Jared FlittonRoy$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.